TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NEO

NeoGenomics Inc

Healthcare · Diagnostics & Research

19.90$ +0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement NEO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+14.6% +144.6% -1.6% +15.2% +47.7% +8.7% +9.0% +5.2% +16.1% +11.6% +10.1%
+20.9% +138.6% +3.4% +8.1% +41.8% +22.0% +15.0% +8.3% +7.8% +6.8% +20.1%
+7.5% +152.3% -7.6% +24.8% +54.7% -5.6% +0.6% +0.4% +30.2% +18.6% -2.6%
+56.1% +10.7% -21.8% -17.5% +182.8% -3.0% +165.8% +38.6% -9.9% +14.1% +19.0%
+41.3% +90.1% +38.8% -4.4% +50.9% +12.3% +53.9% -4.9% -0.7% +8.0% +21.0%
+28.3% +94.3% +3.2% +18.3% +56.8% +8.7% +53.0% +13.0% +2.0% +8.5% -8.8%
-354.1% +12.7% +246.0% +29.5% -207.6%
-8.1% +1,070.7% -44.6% +12.5% -40.4% +89.0% +17.1% -7.8% -8.9% -4.2% -43.3%
-448.3% -4.7% -485.6%
-1,344.6% -468.3%
-323.9% +203.3% -47.9% -300.1%
-55.4% +623.2% +4.7% +19.7% +18.4% -7.4% +33.4% -277.1%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?